By Josh White
Date: Wednesday 10 Sep 2025
(Sharecast News) - Novo Nordisk announced plans to cut 9,000 jobs, around 11% of its global workforce, on Wednesday, as part of a sweeping restructuring aimed at restoring growth in its obesity and diabetes business.
The Danish drugmaker, best known for its Wegovy and Ozempic treatments, said roughly 5,000 of the...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news